The most common serious complication is acute respiratory distress syndrome (ARDS). For some however, the disease progresses to a more severe state with one or more complications and where ICU-care might be needed. Most Patients with COVID-19 have mild symptoms such as fever, cough, fatigue and dyspnea usually appearing within approximately 5 days. It has also placed a great burden on the healthcare sector with high numbers of hospital and intensive care unit (ICU) admissions. Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the end of 2019, the virus has spread rapidly throughout the world causing the corona virus disease 2019 (COVID-19) pandemic, resulting in major disruptions to everyday life and a large number of deaths.
#Physiological dead space full#
Researchers who meet the criteria for access to confidential information and are interested in the full data set are kindly asked to contact who represents the institution of surgical sciences at Uppsala University which owns the data that this study is based on.įunding: The authors received no specific funding for this work.Ĭompeting interests: The authors have declared that no competing interests exist. The statistical analyses themselves are include in full as supporting information as they contain no sensitive information. This was done to in order to comply with our ethical approval, Swedish data protection laws and the EU General Data Protection Regulation in order to ensure the participants privacy. We have after consulting the Swedish Ethical Review Authority, anonymized the participants by removing age, gender, inclusion time and date from the minimal data set that we include as supporting information with this manuscript. As the data set used for the statistical analysis in this study contains sensitive information that could be used to identify individual participants, and could therefore compromise their privacy, we are unable to share this data in full. 2020-02231) limits us to only sharing anonymized data that cannot be used to identify individual participants. Our ethical approval from the Swedish Ethical Review Authority (EPA No. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.ĭata Availability: All relevant data are within the paper and its Supporting Information files.
Received: Accepted: AugPublished: September 2, 2021Ĭopyright: © 2021 Mälberg et al. PLoS ONE 16(9):Įditor: Chiara Lazzeri, Azienda Ospedaliero Universitaria Careggi, ITALY Citation: Mälberg J, Hadziosmanovic N, Smekal D (2021) Physiological respiratory parameters in pre-hospital patients with suspected COVID-19: A prospective cohort study.
0 kommentar(er)
